The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurotoxicity research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03033775PMID 15639797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.

  2004cited by this paper
• Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity

  2004influential reference
• Kennedy's disease: pathogenesis and clinical approaches

  2004cited by this paper
• Caspase‐mediated proteolysis of the polyglutamine disease protein ataxin‐3

  2004influential reference
• Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

  2004influential reference
• Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6.

  2003cited by this paper
• Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity*

  2003cited by this paper
• Domain architecture of the polyglutamine protein ataxin‐3: a globular domain followed by a flexible tail

  2003cited by this paper
• Hprt(CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine

  2003cited by this paper
• Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

  2003cited by this paper
• Depletion of wild‐type huntingtin in mouse models of neurologic diseases

  2003cited by this paper
• The hunt for huntingtin function: interaction partners tell many different stories.

  2003cited by this paper
• Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.

  2003cited by this paper
• SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity.

  2003cited by this paper
• Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin

  2003cited by this paper
• Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.

  2003cited by this paper
• Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease

  2003cited by this paper
• Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein

  2003cited by this paper
• Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-( 1 , 4 , 5 ) Triphosphate

  2003cited by this paper
• Molecular investigation of TBP allele length: a SCA17 cellular model and population study.

  2003cited by this paper
• Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates

  2003cited by this paper
• Transcriptional abnormalities in Huntington disease.

  2003cited by this paper
• Kennedy's Disease

  2003cited by this paper
• Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.

  2003cited by this paper
• Role of proteolysis in polyglutamine disorders

  2003cited by this paper
• Implications of a polyglutamine tract in the function of the human androgen receptor.

  2003cited by this paper
• Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.

  2002influential reference
• Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases.

  2002cited by this paper
• Calpain Activation in Huntington's Disease

  2002influential reference
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

  2002influential reference
• Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion

  2002cited by this paper
• Modulation of polyglutamine-induced cell death by genes identified by expression profiling.

  2002cited by this paper
• Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy*

  2002influential reference
• Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities*

  2002cited by this paper
• Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice

  2002cited by this paper
• Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain

  2002influential reference
• Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

  2002cited by this paper
• Polyglutamine repeat length-dependent proteolysis of huntingtin.

  2002influential reference
• Lessons from animal models of Huntington's disease.

  2002influential reference
• Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease

  2002influential reference
• Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.

  2002cited by this paper
• Expression of ataxin-7 in CNS and non-CNS tissue of normal and SCA7 individuals

  2002cited by this paper
• A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation.

  2002cited by this paper
• Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis

  2002cited by this paper
• A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.

  2002cited by this paper
• Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content.

  2002influential reference
• Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

  2002cited by this paper
• Mutant protein in Huntington disease is resistant to proteolysis in affected brain

  2001cited by this paper
• Spinocerebellar ataxia type 7 (SCA 7) (特集 脊髄小脳変性症の最新の話題)

  2001cited by this paper
• A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems.

  2001cited by this paper
• Identification and expression of a mouse ortholog of A2BP1

  2001cited by this paper
• Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells

  2001cited by this paper
• Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.

  2001cited by this paper
• Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3.

  2001cited by this paper
• Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis

  2001cited by this paper
• Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.

  2001cited by this paper
• The Role of Protein Composition in Specifying Nuclear Inclusion Formation in Polyglutamine Disease*

  2001cited by this paper
• Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.

  2001cited by this paper
• SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.

  2001cited by this paper
• SCA1 molecular genetics: a history of a 13 year collaboration against glutamines.

  2001cited by this paper
• SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.

  2001cited by this paper
• Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

  2001cited by this paper
• Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease Striatum

  2001cited by this paper
• Nuclear Relocation of Normal Huntingtin

  2001cited by this paper
• Spinocerebellar ataxia type 6: channelopathy or glutamine repeat disorder?

  2001influential reference
• Neuronal intranuclear inclusions in spinocerebellar ataxia type 2 : Triple-labeling immunofluorescent study

  2001cited by this paper
• CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.

  2001cited by this paper
• Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations

  2000influential reference
• Expression Analysis of Ataxin‐7 mRNA and Protein in Human Brain: Evidence for a Widespread Distribution and Focal Protein Accumulation

  2000cited by this paper
• Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

  2000cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• A novel protein with RNA-binding motifs interacts with ataxin-2.

  2000cited by this paper
• Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human

  2000influential reference
• Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.

  2000cited by this paper
• Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3

  2000cited by this paper
• Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

  2000cited by this paper
• Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches

  2000cited by this paper
• Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice.

  2000cited by this paper
• Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract.

  2000cited by this paper
• Late-onset SCA2: 33 CAG repeats are sufficient to cause disease

  2000cited by this paper
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

  2000cited by this paper
• Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal Cells*

  2000influential reference
• Distribution of ataxin-7 in normal human brain and retina.

  2000influential reference
• A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene : a new polyglutamine disease?

  2000cited by this paper
• Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

  1999influential reference
• Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA.

  1999cited by this paper
• Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

  1999influential reference
• CAG-polyglutamine-repeat mutations: independence from gene context.

  1999cited by this paper
• Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis.

  1999cited by this paper
• High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells.

  1999cited by this paper
• A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

  1999cited by this paper
• Kennedy's Disease

  1999influential reference
• Nuclear targeting of mutant Huntingtin increases toxicity.

  1999cited by this paper
• Expression of ataxin‐2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2

  1999influential reference
• Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

  1999cited by this paper
• Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.

  1999cited by this paper
• Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study.

  1999cited by this paper
• Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease

  1999cited by this paper
• Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?

  1999influential reference
• Nuclear inclusions in spinocerebellar ataxia type 1

  1999cited by this paper

• Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease.

  2019cites this paper
• Gene Therapies for Polyglutamine Diseases.

  2018cites this paper
• Polyglutamine Disorders

  2018cites this paper
• Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents.

  2017cites this paper
• Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.

  2017cites this paper
• Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders.

  2017cites this paper
• The RNA binding protein MEX-3 retains asymmetric activity in the early Caenorhabditis elegans embryo in the absence of asymmetric protein localization.

  2015cites this paper
• Silencing Mutant ATXN 3 Expression Resolves Molecular Phenotypes in SCA 3 Transgenic Mice

  2013cites this paper
• Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice.

  2013cites this paper
• Proteasome-mediated processing of Def1: a critical step in the cellular response to DNA damage

  2013cites this paper
• Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease.

  2012cites this paper
• 6 Machado-Joseph Disease / Spinocerebellar Ataxia Type 3

  2012cites this paper
• Machado-Joseph disease/spinocerebellar ataxia type 3.

  2012cites this paper
• Characterization of Ubiquitin-mediated Protein Quality Control in the Nucleus

  2012cites this paper
• Calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease

  2012cites this paper
• Kennedy's disease: clinical significance of tandem repeats in the androgen receptor.

  2012cites this paper
• Small Changes, Big Impact

  2011cites this paper
• Disorder targets misorder in nuclear quality control degradation: a disordered ubiquitin ligase directly recognizes its misfolded substrates.

  2011cites this paper
• Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.

  2011cites this paper
• Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides.

  2011cites this paper
• Neurotoxic protein oligomerisation associated with polyglutamine diseases

  2010cites this paper
• Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments.

  2009cites this paper
• A splice variant of the TATA-box binding protein encoding the polyglutamine-containing N-terminal domain that accumulates in Alzheimer's disease.

  2009cites this paper
• [The complexes of degenerative dementias: an evolution from disease to spectrum].

  2009cites this paper
• Biochemical, cellular and behavioural aspects of neurodegeneration: The view from down under

  2009cites this paper
• Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity*

  2008cites this paper
• A polymer physics perspective on driving forces and mechanisms for protein aggregation.

  2008cites this paper
• Tandem repeats in human disorders: mechanisms and evolution.

  2008cites this paper
• Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus.

  2008cites this paper
• Cellular pathways leading to neuronal dysfunction and degeneration.

  2007cites this paper
• INCLUSION FORMATION BY ATAXINS -1, -2, -3, AND -7

  2007cites this paper
• 49 – Spinobulbar Muscular Atrophy (Kennedy's Disease)

  2007cites this paper
• Neurotoxins and neurotoxicity mechanisms. an overview

  2006cites this paper
• De Novo Appearance and “Strain” Formation of Yeast Prion [PSI+] Are Regulated by the Heat-Shock Transcription Factor

  2006cites this paper
• Journal Articles

  1983cites this paper